Monthly Archives: January 2014

An App to improve spontaneous adverse event reporting

Patient reporting of suspected adverse drug reactions (ADRs) has the potential to add value to pharmacovigilance by: Addressing ADR under-reporting Identifying different types of drugs and reactions to those reported by healthcare professionals (HCPs) Generating potential new signals, and Describing

Posted in Apps, Patient Safety, Regulation, Software Development, Technology, Validation

MCT-Congress: Going Mobile with Clinical Trials

We are pleased to announce that Virtual PV will be exhibiting its validated mobile app for reporting adverse events (AEs) at the MCT conference in Edinburgh between March 20 – 21, 2014 and we hope you will be able to join

Posted in Apps, Events, Patient Safety, Software Development, Technology, Uncategorized, Validation

FDA to produce drug shortages smartphone app

The US drugs regulator is looking to create a new smartphone app to help with the continuing problem of drug shortages. There is already an unofficial app called ‘RxShortages’ which has been available since 2010 and relies on information from

Posted in Apps, News, Regulation, Software Development, Technology

Upcoming 2014 mHealth Events

Social Media in the Pharma Industry, London, England, 22-23 January 2014 mHealth Technologies for At-Risk Communities, UCLA, California, 23 January 2014 National Health Summit, Dublin, Ireland, 19 February 2014 Mobile World Congress, Barcelona, Spain, 24-26 February 2014 Mobile Health Strategies

Posted in Uncategorized

App for Older Adults with Cognitive Disabilities

The Art in the Moment app, developed by SchwarTech Consulting LLC with funding from the Alzheimer’s Foundation of America, uses selected works of art found in The Art Institute of Chicago’s collection to stimulate users’ minds through posed questions (audibly

Posted in Apple, Apps, Design, Software Development, Technology

103 FDA Regulated Mobile Medical Apps

At the end of 2013, MobiHealthNews has found more than 103 mobile medical apps in FDA’s databases for Class I, Class II, and Class III devices.

Posted in Uncategorized